Diagnosis, Treatment and Prevention of Age-Related Macular Degeneration (Record no. 21061)

MARC details
000 -LEADER
fixed length control field 01984nam a2200133Ia 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220616s9999||||xx |||||||||||||| ||und||
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783040000000
245 #0 - TITLE STATEMENT
Title Diagnosis, Treatment and Prevention of Age-Related Macular Degeneration
546 ## - LANGUAGE NOTE
Language note English[eng]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element aflibercept monotherapy||polypoidal choroidal vasculopathy||neovascular age-related macular degeneration||good baseline visual acuity||ForeseeHome AMD Monitoring System®||AREDS2-HOME study||age-related macular degeneration||exudation||optical coherence tomography angiography||anti-vascular endothelial growth factor||brolucizumab||epithelial tear||optical coherence tomography||Sorsby’s fundus dystrophy||Sorsby||hereditary retinal dystrophy||choroidal neovascularisation||macular neovascularization||anti-VEGF treatment||long-term FU||treatment outcome||emerging treatment||neovascular age-related macular degeneration (nAMD)||Vascular Endothelial Growth Factor (VEGF)||cataract surgery||clinical trials||real-world evidence||AMD||oct-angiography||fellow eye||choriocapillaris||quiescent macular neovascularization||ranibizumab||aflibercept||anti-VEGF||visual acuity||reading acuity||disease activity||treatment change||treat and extend||switch therapy||retina||choroidal neovascularization||angiogenesis||meteorin||therapeutic innovation||prevention||nutrients||lifestyle||treatment-naive||anti–vascular endothelial growth factor||cardiovascular risk factors||arterial hypertension||macula-off rhegmatogenous detachment||superficial perifoveal capillary plexus||retinal deep perifoveal capillary plexus||identification||risk||Delphi||STARS®||food supplement||bevacizumab||meta-analysis||meta-regression||n/a||age-related macular degeneration (AMD)||comparative therapies||effectiveness||intravitreal anti-vascular endothelial growth factor||treat-and-extend||pro re nata regimen
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Kodjikian, Laurent
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://mdpi.com/books/pdfview/book/5347">https://mdpi.com/books/pdfview/book/5347</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type E-Books
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
        Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre 16/06/2022   16/06/2022 16/06/2022 E-Books